China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) agreed to acquire 50.1% stake in Shenzhou Biology & Technology Co., Ltd from Aerospace Shenzhou Biology & Technology Group Co., Ltd , China Aerospace Investment Holdings Ltd , China Spacesat Co.,Ltd. (SHSE:600118) and Beijing Dawn Aerospace Bio-tech Co., Ltd. for approximately CNY 500 million on August 1, 2022.Aerospace Shenzhou Biology & Technology Co., Ltd holds 21.88% of Shenzhou Biology & Technology Co., Ltd., 16.33% of Shenzhou Biology & Technology Co., Ltd. held by Aerospace Investment Holdings Co., Ltd, 8.33% of Shenzhou Biology & Technology Co., Ltd. by China Spacesat Co.,Ltd., and 3.57% of Shenzhou Biology & Technology Co., Ltd. by Beijing Dawn Aerospace Bio-tech Co., Ltd. This has been approved in the 18th Meeting of the Company's 9th Directorate held on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.6 CNY | +0.65% | -4.32% | -4.73% |
Apr. 30 | China Spacesat Swings to Q1 Loss as Operating Income Plunges 75% | MT |
Apr. 29 | China Spacesat Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
24.6 CNY | +0.65% | -4.32% | 4B | ||
22.64 CNY | -2.08% | -2.83% | 3.27B | ||
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.73% | 4B | |
+59.34% | 4.88B | |
-3.19% | 2.27B | |
+24.40% | 1.43B | |
+1.89% | 899M | |
-5.87% | 801M | |
+134.54% | 731M | |
-19.43% | 590M | |
-50.70% | 549M | |
+74.15% | 438M |
- Stock Market
- Equities
- 600118 Stock
- News China Spacesat Co.,Ltd.
- China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire 50.1% stake in Shenzhou Biology & Technology Co., Ltd. for approximately CNY 500 million.